GLP-1 agonists also reduced headache risk, with the most significant effect at 3 months (RR: 0.69), remaining statistically significant at 6, 12, and 24 months
Two have regulatory histories worth knowing: BPI Labs received an FDA warning letter in March 2025, and Olympia Pharmaceuticals received an FDA Form 483 in May 2024
Damages, in this context, denote the comprehensive sum of losses, both economic and non-economic, that are associated with an event or the utilization of a hazardous medication
Dramatic swings between very low-carb days and high-carb days can cause blood sugar instability
Experience the sleek elegance of our Modern Wellness Retreat Sauna
Avoid making multiple digestive changes at once